#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary amyloidosis Neuroendocrine cell hyperplasia of infancy Duchenne muscular dystrophy gene carrier White matter lesion C3 glomerulopathy Endometrial cancer Emphysema Acquired C1 inhibitor deficiency Progressive familial intrahepatic cholestasis B-cell small lymphocytic lymphoma refractory Acute hepatic failure Anti-neutrophil cytoplasmic antibody positive vasculitis Heritable pulmonary arterial hypertension Biotinidase deficiency Erythema multiforme More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Treatment Waldenstrom’s macroglobulinaemia refractory – Basic Information Systemic sclerosis pulmonary – Trials in Disease Krabbe’s disease Pelizaeus-Merzbacher disease – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Treatment Paroxysmal nocturnal haemoglobinuria – Life with Disease Alternating hemiplegia of childhood – Diagnostics Turner’s syndrome – Trials in Disease Alternating hemiplegia of childhood – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enx-101 Citalopram Hydrobromide Specific Nucleic Acid Sna-Xfsa Istem-01 Meglumine Gadoterate INCB123667 Labetalol Hydrochloride Clindamycin Arrhenatherum Elatius Fluorodopa (18F) Ly3871801 Blomia Tropicalis Buloxibutid BENZYLPENICILLIN PROCAINE ZUNIBERGENE ROCPARVOVEC Methotrexate Sodium Meropenem Anhydrous Mk-1084 Dl-Alpha-Tocopherol Hyoscine Butylbromide More therapies…

    Learn about Your Condition

    Growth hormone deficiency Renal cancer metastatic Immunosuppression Osteosarcoma Oesophageal adenocarcinoma Respiratory failure Hypotransferrinaemia Fallopian tube cancer stage IV Familial hypertriglyceridaemia Post procedural infection Breast cancer metastatic Pulmonary alveolar haemorrhage Systemic infection Prostate cancer recurrent Circulatory collapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

COVID-19

  • Study on the Immune Response to Bretovameran COVID-19 mRNA Vaccine in Healthy Adults Aged 18-40

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Belgium

  • Study on the Safety and Immune Response of BIMERVAX as a COVID-19 Booster in Adolescents Aged 12 to 17 Years

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER
    Spain

  • Study on the Immune Response of COVID-19 Vaccine Tozinameran with Flu Vaccine Combinations in Adults Aged 65 and Over

    Not recruiting

    2 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • Tozinameran
    • B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)
    Belgium The Netherlands

  • Study on the Safety of BIMERVAX and Fluad Tetra for COVID-19 and Influenza in Adults Over 65 Who Are Fully Vaccinated Against COVID-19

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Influenza
    • COVID-19
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER
    • A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
    Spain

  • Study on ITPP and Sodium Chloride for Patients with COVID-19 and Other Lung Infections Facing Breathing Problems

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Sodium Chloride
    Poland

  • Study on the Use of Casirivimab, Cilgavimab, Sotrovimab, and Nirmatrelvir for Patients with COVID-19 Infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Casirivimab
    • Cilgavimab
    • Sotrovimab
    The Netherlands
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!